Pharmaceutical

Novo Nordisk enters deal to develop obesity therapy

Novo Nordisk has entered into a deal with Flagship Pioneering and Metaphore Biotechnologies to develop therapeutics for obesity.

May 11, 2024 - 04:00
Novo Nordisk enters deal to develop obesity therapy
Novo Nordisk has entered into a deal with Flagship Pioneering and Metaphore Biotechnologies to develop therapeutics for obesity.
Read the original article

Tags:

Previous Article

Attovia secures $105m to advance development of lead programmes

Next Article

KITECH develops deformable energy storage device via laser technology

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Risk sharing agreements soar as market access risk increases

Risk sharing agreements soar as market access risk incr...

Mar 19, 2023

Absci and Caltech receive grant to develop HIV therapeutic vaccine

Absci and Caltech receive grant to develop HIV therapeu...

Aug 12, 2023

STAT+: Sen. Warren pushes for more data on Medicare Advantage coverage hurdles, denials

STAT+: Sen. Warren pushes for more data on Medicare Adv...

Dec 9, 2023